Structure-activity relationships of K+ channel openers
- PMID: 2256183
- DOI: 10.1016/0165-6147(90)90149-3
Structure-activity relationships of K+ channel openers
Abstract
Seven groups of synthetic agent, distinguished by a combination of their chemical and pharmacological characteristics exert some or all of their effects by opening plasmalemmal K+ channels primarily in smooth muscle. Progress over the past two years now allows broad structure-activity relationships to be formulated within many of the individual groups of agent. Gillian Edwards and Arthur Weston review the historical basis of these discoveries and comment on the significance of new developments. They focus on the search for tissue and channel selectivity, two factors likely to be important for the successful clinical deployment of these substances as antihypertensive and bronchodilator agents.
Similar articles
-
Recent progress in potassium channel opener pharmacology.Biochem Pharmacol. 1992 Jan 9;43(1):47-54. doi: 10.1016/0006-2952(92)90659-7. Biochem Pharmacol. 1992. PMID: 1734898 Review.
-
Potassium channel openers as potential therapeutic weapons in ion channel disease.Kidney Int. 2000 Mar;57(3):838-45. doi: 10.1046/j.1523-1755.2000.00923.x. Kidney Int. 2000. PMID: 10720937 Review.
-
Latest developments in K-channel modulator pharmacology.Z Kardiol. 1991;80 Suppl 7:1-8. Z Kardiol. 1991. PMID: 1792813 Review.
-
Is there a therapeutic future for "potassium channel openers'?Clin Sci (Lond). 1996 Dec;91(6):651-63. doi: 10.1042/cs0910651. Clin Sci (Lond). 1996. PMID: 8976800 Review.
-
Current trends in the study of potassium channel openers.Gen Pharmacol. 1993 Mar;24(2):275-81. doi: 10.1016/0306-3623(93)90303-f. Gen Pharmacol. 1993. PMID: 8482511 Review.
Cited by
-
Effects of potassium channel openers and their antagonists on rat locus coeruleus neurones.Br J Pharmacol. 1993 Jun;109(2):308-15. doi: 10.1111/j.1476-5381.1993.tb13571.x. Br J Pharmacol. 1993. PMID: 8358535 Free PMC article.
-
Comparison of in vitro effects of cicletanine, its enantiomers and major metabolite on rat thoracic aorta.Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):548-52. doi: 10.1007/BF00166749. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8391656
-
ATP-regulated K+ channel in mitochondria: pharmacology and function.J Bioenerg Biomembr. 1996 Apr;28(2):147-52. doi: 10.1007/BF02110645. J Bioenerg Biomembr. 1996. PMID: 9132413 Review.
-
Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas.Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5438-42. doi: 10.1073/pnas.88.12.5438. Proc Natl Acad Sci U S A. 1991. PMID: 1647032 Free PMC article.
-
An analysis of the nitrate-like and K channel opening actions of KRN2391 in canine coronary arterial smooth muscle.Br J Pharmacol. 1991 Dec;104(4):829-38. doi: 10.1111/j.1476-5381.1991.tb12514.x. Br J Pharmacol. 1991. PMID: 1810597 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous